KROS — Keros Therapeutics Share News
0.000.00%
Last trade - 00:00- $223.65m
- -$33.96m
- $244.06m
Keros Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Keros Therapeutics Inc expected to post a loss of 24 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-JPMorgan Chase, Capri, Novavax
U.S. STOCKS ON THE MOVE-AppLovin, Ligand Pharma, Dexcom
Keros Therapeutics rises after adoption of poison pill, review of strategic options
U.S. STOCKS ON THE MOVE-CarMax, Red Cat, Lucid Diagnostics
U.S. STOCKS ON THE MOVE-Ford Motor, General Motors, AES
Keros Therapeutics adopts poison pill as shareholders seek control (updated)
Keros Therapeutics rises after adoption of 'poison pill' plan, review of strategic options
Keros Therapeutics adopts 'poison pill' plan
Brief: Keros Therapeutics Announces Review Of Strategic Alternatives
U.S. RESEARCH ROUNDUP-Aerovironment, Apple, Starbucks
Brief: Keros Therapeutics Announces Initial Topline Results From Phase 1 Clinical Trial Of KER-065 In Healthy Volunteers
Keros Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
Factbox: Fat, not muscle: drugmakers in race for next weight-loss breakthrough
Brief: Keros Therapeutics Announces Effectiveness Of Global License Agreement With Takeda
U.S. RESEARCH ROUNDUP- Hubspot, Morgan Stanley, US Bancorp
U.S. STOCKS ON THE MOVE-Wolfspeed, Netflix, Spotify
U.S. STOCKS ON THE MOVE-BlackRock, WEX, Big banks